Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00225576 · ClinicalTrials.gov registry record · Phase 2
Statewide Implementation of Electronic Health Records
A Phase 2 study of Medication Errors, sponsored by Agency for Healthcare Research and Quality (AHRQ).
- Completed
- Registry status
- Phase 2
- Development phase
- 2,030
- Enrollment target
- 1
- Study location
NCT00225576: Completed Phase 2 study of Medication Errors, sponsored by Agency for Healthcare Research and Quality (AHRQ).
NCT00225576 is a Phase 2 study of Medication Errors that has completed, run by Agency for Healthcare Research and Quality (AHRQ). The registered enrollment target is 2,030 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1426% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00225576, a Phase 2 study of Medication Errors, has completed, sponsored by Agency for Healthcare Research and Quality (AHRQ).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2,030 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the effects of Electronic Health Record use on medication error rates in primary care office practices. Hypothesis: Adoption of Electronic Health Records through this program will reduce medication errors
Conditions Studied
Interventions
- OTHER Electronic Health Record Implementation
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,030 participants |
| Start Date | 2005-09 |
| Est. Completion | 2012-12 |
| Phase | Phase 2 |
What the finished NCT00225576 record still lists
NCT00225576 is an interventional study that assigns participants to a tested intervention. Its 2,030 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1426% higher).
The record links to 1 condition, with Medication Errors appearing as the primary indexed condition, and to 1 intervention - of which Electronic Health Record Implementation is the first listed.
NCT00225576 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00225576 about?
NCT00225576 is a clinical study titled "Statewide Implementation of Electronic Health Records". To determine the effects of Electronic Health Record use on medication error rates in primary care office practices. Hypothesis: Adoption of Electronic Health Records through this program will reduce medication errors
What is the current status of trial NCT00225576?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,030 participants. The study started on 2005-09. Estimated completion is 2012-12.
What conditions does trial NCT00225576 study?
This clinical trial studies the following conditions: Medication Errors.
What interventions are being tested in trial NCT00225576?
The interventions under investigation include: Electronic Health Record Implementation (OTHER).
Who is sponsoring clinical trial NCT00225576?
This trial is sponsored by Agency for Healthcare Research and Quality (AHRQ), which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00225576 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Medication Errors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00225576's enrollment target sits among peer trials
2,030 8th of 2000 higher than 1,993 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04216732 · 2,030 participants
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
- NCT05625659 · 2,032 participants · NA
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
- NCT06825897 · 2,039 participants · NA
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
- NCT05059444 · 2,020 participants
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia